doi: 10.1016/S0140-6736(80)92338-7 81 BischoffSCBernalWDasarathySMerliMPlankLDSchtzTet al
Functionalized nanoparticles enable controlled release and TME-specific targeting, enhancing the efficacy of combined therapies
Circulation 2021;143:20072022

Coffin 3 , (1)Division of Gastroenterology, University of British Columbia, BC, Canada, (2)The Ottawa Hospital, Ottawa, ON, Canada, (3)Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, (4)Department of Medicine, University of Alberta, Edmonton, AB, Canada, (5)University Health Network, Toronto, Ontario, Canada, (6)Department of Medicine, University of Toronto, Toronto, ON, Canada, (7)Haskayne School of Business, University of Calgary, AB, Canada, (8)Toronto Liver Center, Toronto, Ontario, Canada, (9)Pacific Gastroenterology Associates, Vancouver, BC, Canada, (10)Cisss Laurentides, St-Jerome, Clinique Mdicale Urbaine Du Quartier Latin, QC, Canada, (11)Department of Medicine, McGill University Health Centre, Montreal, QC, Canada, (12)Mcmaster University, Hamilton, on, Canada, (13)Cit-De- La- Sant De Laval, Laval, QC, Canada, (14)Division of Gastroenterology, Health Sciences, Dalhousie University, NS, Canada, (15)National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada, (16)Department of Medicine, McGill University Health Centre, Westmount, QC, Canada Background: Although Canada has a universal health care system, this does not include prescription drug benefits and provincial drug coverage formulary is variable
